Search Results

program in the Department of Pharmaceutical Sciences at the Faculty of Pharmacy and the Department of Biochemistry He is the scientific founder of two biotech companies, ModMab Therapeutics , and AntlerA Therapeutics Angers was named Director of the Donnelly Centre of Cellular and Biomolecular Research at the University Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Schulte is a Professor in receptor pharmacology and research group leader for the section Receptor Biology He has a background in biochemistry from the Free University in Berlin/Germany and a Ph.D. in molecular Melbourne Australia, GPCR pharmacology; 2006) before starting his independent research team "Receptor Biology Molecular Pharmacology, British Journal of Pharmacology, Pharmacological Reviews, and The Journal of Biological is on Frizzled signaling and pharmacology aiming to understand the role of WNT/Frizzled signaling in biology

culture of normal and malignant pancreatic tissue, allowing advances in sequencing, target discovery and biomarker interest in science originated from a young age and his desire to gain more knowledge about cancer biology They also shared their personal experiences and interest in the field of biology. proposed further exploration of dosage and length of treatment in a mouse model and suggested using a biosensor-based Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

A fungal serine protease allergen with GPCR-modulating features was discovered as a new biomarker and Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Jens Carlsson, Professor of Computational Biochemistry at Uppsala University, joins Dr. Early-career researchers exploring drug discovery Biotech leaders and R&D strategists Anyone interested in predictive modeling, AI in biology, or structure-function relationships About Jens Carlsson Jens Carlsson is a Professor of Computational Biochemistry at Uppsala University, where his research group Trained initially as a biotechnology engineer, Jens discovered his true calling during an internship

Stalled Pipeline Progression ❌ Uncertainty in GPCR Investments Advisory Focus Areas Expert support for Biotech innovators, VC investors and CRO partners Biotech Pipeline Acceleration For Biotech Leaders & Scientists I integrate seamlessly with biotech, VC, and CRO teams as a trusted, objective partner. Biology-First, Data-Driven Solutions Every recommendation is rooted in GPCR biology, pharmacology experience With over two decades dedicated to GPCR pharmacology across biotech, academia, and the non-profit sector

Pharmacology #DrugDiscovery #AllostericModulation #Kinetics #AssayDevelopment #EarlyDiscovery #PharmaR&D #BiotechInnovation

David Sykes " David Andrew Sykes, BSc Hons Pharmacology, MSc Molecular Biology and Biochemistry, PhD Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Lauren Slosky About Irfan Dhanidina "My interest in oncology research led me to pursue a BSc in Biology & Economics from Carleton University, and an MSc in Biotechnology at McGill. In my role at Orion Biotechnology, I work at the intersection of science and business, which includes Caron received a BS in Biology and BA in Philosophy at Emory University and a PhD at Duke University Caron has received numerous awards including a Burroughs Wellcome Fund Career Award in the Biomedical

She received her BSc in Human Biology from King’s College London in 1997, and while her Ph.D. commenced Her research focuses on understanding the fundamental cell biological mechanisms regulating GPCR activity Her work is currently funded by Biotechnology and Biological Sciences Research Council (BBSRC), Diabetes Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

activation mechanism of this family of G protein-coupled receptors using innovative approaches, including biosensors Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

FB is recognized for her expertise and pioneering works in the field of biological and pathological functions Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

based in South Korea, has recently been named President of GPCR Therapeutics, USA, a newly incorporated Biotechnology Cardarelli is a drug development leader with extensive experience driving drug discovery teams in bringing biologics She has expertise in cell biology, pharmacology, translational medicine, oncology, immuno-oncology, immunology Previously, she held the position of Vice President of Cell Biology & Pharmacology, at Bristol-Myers She has extensive experience working with Biologics, and Antibody Drug Conjugates as well as experience

Andrew Tobin Andrew Tobin studied Biochemistry at Queen Mary College, the University of London obtaining research laboratory of around 15 staff supported by basic research grants investigating aspects of disease biology Andrew is translating fundamental findings to commercial products is Keltic Pharma Therapeutics Ltd , a biotechnology Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Les Houches, France in 1979 where he was exposed for the first time to the nascent field of membrane biophysics Rockefeller University with a Howard Hughes Medical Institute appointment, Tom advanced a series of novel biochemical and biophysical assay platforms, including FTIR and Raman microprobe spectroscopy to study micro-quantities applications included “targeted photo-crosslinking,” and more recently, the parallel development of bioorthogonal Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

He later joined the laboratory of eminent biochemical pharmacologist, Dr. Alfred G. His training has provided a strong foundation and appreciation for the applications of pharmacology, biochemistry and structural biology to delineate mechanisms of action. The Sunahara lab utilizes biochemical, biophysical and pharmacological methodologies to study GPCR-G Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

From DuPont to Cerevel, he focused on GPCR biology and became one of the few deep experts still standing

She completed her undergraduate education at Providence College, receiving a B.S. in Biology and a B.A Victoria started her Ph.D. at the Tri-Institutional Ph.D. program in Chemical Biology, where she joined as a therapeutic strategy. " Victoria Rasmussen on the web Tri-Institutional PhD Program in Chemical Biology GPCR About Madelyn Moore "Madelyn (Maddi) earned her B.S. in Biochemistry from the University of Minnesota-Duluth Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

GPCR Foundry is a nonprofit platform designed to help biotech leaders accelerate GPCR drug discovery Why Biotechs choose Dr. GPCR Foundry? The Foundry is built for GPCR biotech companies at the discovery stage . 🔬 Validate your first target Build credibility and visibility among scientists, biotechs, and CRO partners worldwide. with structured frameworks tailored for biotech growth.

GPCR Ecosystem: uniting scientists, biotech, and innovators to advance GPCR research worldwide. Who We Are We are a global network of scientists, biotech innovators, pharma professionals, CRO leaders & Get Our Weekly News See Why it Matters 6,600+ followers 200+ Research Labs 1,500+ Scientists 50+ Biotech Now, it's a global ecosystem of scientists, biotech teams, CRO leaders, and trainees working to move Premium Members Include: ✔ Drug hunters at early-stage biotechs ✔ CRO leaders building assays and tools

Fast-track your biotech investments with VC Insights. Home About Services News Get in Touch Welcome VC Insights Fast Track Your Next Biotech Bet Get decision-grade talk about how I support GPCR discovery, pharmacology strategy, and cross-functional execution across biotech

Join the GPCR Retreat: Exploring the Frontiers of GPCR Biology!

Frequently asked questions University Vault Premium Pricing GPCR Masterclass YC-Biotech YC-VC YC-CRO

GPCRs are among the most powerful and complex targets in biomedical research. Elodie Dupuis earned her Master’s degree in biology and biotechnology engineering from the University Mathis holds a biotechnology engineering degree from the National School of Biomolecule Technology of Bordeaux and an MS in biomedical business management from the Grenoble School of Management. Internalization is a core—but often overlooked—dimension of GPCR biology.